Trials / Unknown
UnknownNCT01064570
AIDA 2000 Guidelines
Guidelines for Treatment of Acute Promyelocytic Leukemia
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 1 Year – 60 Years
- Healthy volunteers
- Not accepted
Summary
Prospective use of RT-PCR for PML/RARa might be used to guide a total tehrapy approach in APL, including refined diagnosis, front-line treatment, assessment of response and anticipated salvage therapy for patients who undergo molecular relapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | all-trans retinoic acid (ATRA) |
Timeline
- Start date
- 2000-05-01
- First posted
- 2010-02-08
- Last updated
- 2020-10-14
Locations
3 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01064570. Inclusion in this directory is not an endorsement.